Search Results - "DiMeglio, L. A."

Refine Results
  1. 1

    Insulin dose changes in children attending a residential diabetes camp by Miller, A. R., Nebesio, T. D., DiMeglio, L. A.

    Published in Diabetic medicine (01-04-2011)
    “…Diabet. Med. 28, 480–486 (2011) Aims  To examine the effects of insulin dose adjustments on rates of hypoglycaemia for school‐aged children with Type 1…”
    Get full text
    Journal Article
  2. 2

    Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta by DiMeglio, L.A., Ford, L., McClintock, C., Peacock, M.

    Published in Bone (New York, N.Y.) (01-11-2004)
    “…Bone mineral density (BMD) and fracture rates in children with osteogenesis imperfecta (OI) have been shown to improve with bisphosphonate therapy. There are…”
    Get full text
    Journal Article
  3. 3

    Initial findings: primary diabetes care responsibility among emerging adults with type 1 diabetes post high school and move out of parental home by Hanna, K. M., Weaver, M. T., Stump, T. E., DiMeglio, L. A., Miller, A. R., Crowder, S., Fortenberry, J. D.

    Published in Child : care, health & development (01-01-2013)
    “…Background  Emerging adults with diabetes are assuming diabetes care responsibility, graduating from high school and leaving their parental homes. We examined:…”
    Get full text
    Journal Article
  4. 4

    Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study by DiMeglio, L. A., Kanapka, L. G., DeSalvo, D. J., Anderson, B. J., Harrington, K. R., Hilliard, M. E., Laffel, L. M., Tamborlane, W. V., Van Name, M. A., Wadwa, R. P., Willi, S. M., Woerner, S., Wong, J. C., Miller, K. M.

    Published in Diabetic medicine (01-08-2020)
    “…Aim To assess the associations between demographic and clinical characteristics and sensor glucose metrics in young children with type 1 diabetes, using…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV‐infected children by Miller, TL, Borkowsky, W, DiMeglio, LA, Dooley, L, Geffner, ME, Hazra, R, McFarland, EJ, Mendez, AJ, Patel, K, Siberry, GK, Van Dyke, RB, Worrell, CJ, Jacobson, DL

    Published in HIV medicine (01-05-2012)
    “…Objectives HIV‐infected children may be at risk for premature cardiovascular disease. We compared levels of biomarkers of vascular dysfunction in HIV‐infected…”
    Get full text
    Journal Article
  8. 8

    Disorders of phosphate metabolism by DiMeglio, L A, White, K E, Econs, M J

    “…Correct identification of the disorders of hypophosphatemia and hyperphosphatemia is important for determining therapy. Further research will provide insights…”
    Get more information
    Journal Article
  9. 9

    Disorders of puberty : Inactivating and activating molecular mutations by DIMEGLIO, L. A, PESCOVITZ, O. H

    Published in The Journal of pediatrics (01-07-1997)
    “…Recent developments have increased our understanding of the molecular mechanisms that are responsible for several disorders of puberty. Specific gene mutations…”
    Get full text
    Conference Proceeding Journal Article
  10. 10
  11. 11

    Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: A meta-analysis by Eugster, Erica A., DiMeglio, Linda A., Wright, James C., Freidenberg, Gary R., Seshadri, Roopa, Pescovitz, Ora H.

    Published in The Journal of pediatrics (01-01-2001)
    “…Objective: To investigate adult heights attained by patients with 21-hydroxylase deficiency and to perform a meta-analysis of height outcomes reported in this…”
    Get full text
    Journal Article
  12. 12

    A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta by Dimeglio, L A, Ford, L, McClintock, C, Peacock, M

    “…Bone mineral density and fracture rates in children with osteogenesis imperfecta improve with intravenous bisphosphonates. The efficacy of oral bisphosphonates…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial by Ware, Julia, Boughton, Charlotte K, Allen, Janet M, Wilinska, Malgorzata E, Tauschmann, Martin, Denvir, Louise, Thankamony, Ajay, Campbell, Fiona M, Wadwa, R Paul, Buckingham, Bruce A, Davis, Nikki, Besser, Rachel E J, Weinzimer, Stuart A, Hood, Korey K, Kanapka, Lauren, Kollman, Craig, Beck, Roy W, Hovorka, Roman, Hovorka, R, Thankamony, A, Allen, J M, Boughton, C K, Dunger, D B, Ware, J, Musolino, G, Wilinska, M E, Hayes, J F, Slegtenhorst, S, Ruan, Y, Haydock, M, Mangat, J, Denvir, L, Law, J, Sachdev, P, Saxton, M, Stafford, S, Keeton, R, Cresswell, R, Fazackerley, H, Looby, L, Saddington, C, Smith, V, Verhoeven, V, Bratt, S, Khan, N, Moyes, L, Sandhu, K, West, C, Wadwa, R P, Alonso, G, Forlenza, G, Escobar, E, Jost, E, Messer, L, Campbell, F M, Yong, J, Metcalfe, E, Allen, M, Waheed, S, Exall, J, Tulip, J, Buckingham, B A, Norlander, L, Jacobson, T, Twon, M, Leverenz, B, Keller, J, Dewar, H, Mauras, N, Benson, M, Bird, K, Englert, K, Permuy, J, Ponthieux, K, DiMeglio, L A, Ismail, H, Besser, R EJ, London, R, Ryan, F, Bowen-Morris, J, Law, R, Deakin, M, Phelan, K, Cengiz, E, Van Name, M, Steffen, A, Zgorski, M, Davis, J, Hellman, A, Kanapka, L, McCarthy, C, Chalasani, S, Lanning, M, Eggerman, T, Janicek, R, Gabrielson, D, Castle, J, Green, J, Legault, L, Wysham, C

    Published in The Lancet. Digital health (01-04-2022)
    “…Closed-loop insulin delivery systems have the potential to address suboptimal glucose control in children and adolescents with type 1 diabetes. We compared…”
    Get full text
    Journal Article
  16. 16

    A missense mutation encoding cys(67) --> gly in neurophysin ii is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus by DiMeglio, L A, Gagliardi, P C, Browning, J E, Quigley, C A, Repaske, D R

    Published in Molecular genetics and metabolism (01-01-2001)
    “…Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is an inherited disorder in which progressive degeneration of magnocellular neurons of the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Advances in the Classification and Treatment of Osteogenesis Imperfecta by Thomas, Inas H., DiMeglio, Linda A.

    Published in Current osteoporosis reports (01-02-2016)
    “…Osteogenesis imperfecta (OI) is a rare disorder of type 1 collagen with 13 currently identified types attributable to inherited abnormalities in type 1…”
    Get full text
    Journal Article
  20. 20